Recently, emerging evidence has shown that LPL overexpression or increases in LPL activity can reduce plasma TG content and increase high-density lipoprotein cholesterol (HDL-C) levels [6,7]; however, deficiency of LPL activity leads to hypertriglyceridemia [8]. The gene discussed is LPL; the disease is hypertriglyceridemia.